Fosfomycin for Pseudomonas-related exacerbations of cystic fibrosis.
Faruqi
S
S
McCreanor
J
J
Moon
T
T
Meigh
R
R
Morice
A H
AH
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003550:Cystic Fibrosis / Q000150:complications* / Q000503:physiopathology; D005260:Female; D005578:Fosfomycin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D011552:Pseudomonas Infections / Q000188:drug therapy* / Q000209:etiology* / Q000503:physiopathology; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D012129:Respiratory Function Tests; D016896:Treatment Outcome; D055815:Young Adult
D000900:Anti-Bacterial Agents; D005578:Fosfomycin